(PNTG) Pennant - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US70805E1091
PNTG EPS (Earnings per Share)
PNTG Revenue
PNTG: Home Health, Hospice Care, Senior Living
Pennant Group Inc (NASDAQ:PNTG) is a healthcare services provider operating in the US, focusing on home health, hospice, and senior living services. The companys diversified portfolio includes clinical services, such as therapy and medical social work, as well as residential accommodations and daily living assistance for seniors.
The companys operational footprint spans across multiple states, including Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming, with a mix of home health, hospice, and senior living communities. This geographic diversification likely provides a stable revenue stream and opportunities for growth.
Analyzing the provided
From a fundamental perspective, PNTGs
To achieve this forecast, Pennant Group Inc will likely need to continue executing its growth strategy, expanding its operational footprint, and improving its operational efficiency. As the healthcare services market continues to grow, driven by an aging population and increasing demand for home-based care, PNTG is well-positioned to capitalize on these trends.
Additional Sources for PNTG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
PNTG Stock Overview
Market Cap in USD | 954m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2019-10-01 |
PNTG Stock Ratings
Growth Rating | -11.2 |
Fundamental | 48.7 |
Dividend Rating | 0.0 |
Rel. Strength | 35.3 |
Analysts | 3.75 of 5 |
Fair Price Momentum | 26.48 USD |
Fair Price DCF | 5.42 USD |
PNTG Dividends
Currently no dividends paidPNTG Growth Ratios
Growth Correlation 3m | 79.2% |
Growth Correlation 12m | -35% |
Growth Correlation 5y | -28.4% |
CAGR 5y | 3.12% |
CAGR/Max DD 5y | 0.04 |
Sharpe Ratio 12m | 1.82 |
Alpha | 17.78 |
Beta | 0.698 |
Volatility | 37.28% |
Current Volume | 218k |
Average Volume 20d | 182.6k |
As of June 23, 2025, the stock is trading at USD 27.78 with a total of 217,972 shares traded.
Over the past week, the price has changed by -2.46%, over one month by -1.00%, over three months by +14.37% and over the past year by +23.41%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Pennant (NASDAQ:PNTG) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 48.65 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PNTG is around 26.48 USD . This means that PNTG is currently overvalued and has a potential downside of -4.68%.
Pennant has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold PNTG.
- Strong Buy: 1
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, PNTG Pennant will be worth about 29.3 in June 2026. The stock is currently trading at 27.78. This means that the stock has a potential upside of +5.33%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 33.6 | 21% |
Analysts Target Price | 33 | 18.8% |
ValueRay Target Price | 29.3 | 5.3% |